Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B

BACKGROUND/AIMS: Despite the potent suppression of the hepatitis B virus with modern antiviral agents, only a minority of HBeAg-positive patients achieve hepatitis B e antigen seroconversion. We aimed to explore the potential efficacy of combination therapy consisting of pegylated interferon (p-IFN)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wi, Chung-Il, Kim, W. Ray, Gross, John B., Stadheim, Linda M., Poterucha, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933423/
https://www.ncbi.nlm.nih.gov/pubmed/26190580
http://dx.doi.org/10.5009/gnl14256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933423/
https://www.ncbi.nlm.nih.gov/pubmed/26190580
http://dx.doi.org/10.5009/gnl14256

Ejemplares similares